| Faculty | Relationship Identified With: |
| Roopen Arya | Speaker’s Bureau: Sanofi, Cardinal Health |
| Fawaz Al-Mufti | Consultant: UCB, Stryker, Penunbra, Cerenovus, AstraZeneca |
| Casey Albin, MD | Nothing to Disclose |
| Sophia Ambruso | Consultant: AstraZeneca |
| Dr. Sonia Anand | Consulting and speaker fees: Bayer AG, Janssen Pharmaceuticals |
| Alessia Argirò | Nothing to Disclose |
| Christos Argyropoulos MD, PhD, FASN | Consultant: Baxter Healthcare, Bayer |
| Sara Azimi | Nothing to Disclose |
| Christie Ballantyne, MD | Grant Research Support: Abbott Diagnostic, Akcea, Amgen, Arrowhead, Esperion, lonis, Novartis, Regeneron, Roche Diagnostic, NIH, AHA, ADA; Consultant- Abbott Diagnostics, Althera, Amarin, Amgen, Arrowhead, Astra Zeneca, Denka Seiken, Esperion, Genentech, Gilead, Illumina, Matinas BioPharma Inc, Merck, New Amsterdam, Novartis, Novo Nordisk, Pfizer, Regeneron, Roche Diagnostic, Sanofi-Synthelabo |
| Geoffrey Barnes, MD, MSc | Consultant: Pfizer, Briston-Myers Squib, Janssen, Boston Scientific, Abbott Vascular; Board of Directors: Anticoagulation Forum |
| Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP | Nothing to Disclose |
| Sheila Bermejo García | Reports honorarium for conferences, consulting fees, and advisory boards from AstraZeneca, Boehringer and Mundipharma |
| Deepak L. Bhatt, MD | Grant/Research Support: Abbott; Afimmune Limited; Amgen Inc.; AstraZeneca Pharmaceuticals; Bayer AG; Boehringer Ingelheim International GmbH; Bristol Myers Squibb; Cardax, Inc.; CHIESI USA, Inc.; CSL Behring; Eli Lilly and Company; Eisai Co., Ltd.; Ethicon; Ferring Pharmaceuticals; Forest Laboratories; Fractyl Laboratories, Inc.; Idorsia Pharmaceuticals Ltd; Ironwood Pharmaceuticals, Inc.; Ischemix; Lexicon Pharmaceuticals, Inc.; Medtronic; Pfizer; PhaseBio Pharmaceuticals, Inc.; PLx Pharma Inc.; Regeneron Pharmaceuticals; Sanofi; Synaptic, The Medicines Company |
| Snehal H. Bhatt, PharmD | Speaker’s Bureau: Janssen Global Services, LLC |
| Bryan Boling | Nothing to Disclose |
| Allison E Burnett PharmD, PhC, CACP | Consultant: Abiomed |
| Mauricio G. Cohen, MD | Consultant/Advisor: Abiomed; AstraZeneca Pharmaceuticals; Medtronic; Merit Medical Systems; Terumo Medical Corporation Speaker’s Bureau: Abiomed; Medtronic; Merit Medical Systems; Terumo Medical Corporation Ownership: Accumed Radial Systems |
| Christopher P. Cannon, M.D. | Research Grants from: Amgen, Better Therapeutics, Boehringer-Ingelheim (BI), Bristol- Myers Squibb (BMS), Daiichi Sankyo, Janssen, Merck, Novo Nordisk, Pfizer; Consulting fees from Aegerion/Amryt, Alnylam, Amarin, Amgen, Applied Therapeutics, Ascendia, BI, BMS, Eli Lilly, Janssen, Lexicon, Merck, Pfizer, Rhoshan, Sanofi; Serves on the Data and Safety Monitoring Boards for the Veteran’s Administration, Applied Therapeutics and NovoNordisk |
| Clara García Carro | Travel and congress fees support from AstraZeneca, Esteve, NovoNordisk, Boehringer Ingelheim Lilly, Astellas, Otsuka, Novartis, Astellas, and Baxter; Scientific lectures, advisory boards and scientific committees organized by AstraZeneca, Boehringer Ingelheim Lilly, Mundipharma, Esteve and NovoNordisk |
| Richard Choi DO | Nothing to disclose |
| Ricardo Correa, MD | Nothing to disclose |
| Claire Davies | Speaker: NovoNordisk, CMM, Astra Zeneca, CareFlow Medicines Management, Diabetes Professional Care, NAPP; Advisor: MTech Access, Roche; Author: Green Light Pharmacy |
| Melanie Davies CBE, MB ChB, MD, FRCP, FRCGP, FMedSci | Consultant, advisory board member, speaker and received grant: Boehringer Ingelheim, Eli Lilly, Novo Nordisk, Sanofi; Board Member: Lexicon, Pfizer, ShouTi Pharma Inc; Speaker: AstraZeneca, Napp Pharmaceuticals, Novartis, Janssen |
| Tejas Desai | Nothing to disclose |
| Dave L. Dixon, PharmaD | Research Funding: Boehringer Ingelheim |
| Kevin Fernando, MD | Consultant/Advisor: AstraZeneca Pharmaceuticals; Bayer AG; Boehringer Ingelheim International GmbH; Bristol Myers Squibb; Eli Lilly and Company; MSD Pharmaceuticals; NAPP Pharmaceuticals Limited; Novo Nordisk A/S; Sanofi Speaker’s Bureau: AstraZeneca Pharmaceuticals; Bayer AG; Boehringer Ingelheim International GmbH; Bristol Myers Squibb; Eli Lilly and Company; MSD Pharmaceuticals; NAPP Pharmaceuticals Limited; Novo Nordisk A/S; Sanofi; Daiichi Sankyo, Amgen & Amarin |
| Ines Fonseca | Speaker, conference support: Novo Nordisk; Conference support: Lilly; Speaker: AstraZeneca |
| Dr GIUSEPPE GALATI | Nothing to disclose |
| Dr Robert P. Giugliano | Clinical Trials/Research Support: Amgen, Anthos Therapeutics, Daiichi Sankyo; Honoraria for Lectures / CME Programs: Amgen, Centrix, Daiichi Sankyo, Dr. Reddy’s Laboratories, Medical Education Resources (MER), Medscape, Menarini, Merck, Pfizer, SAJA Pharmaceuticals, Servier, Shanghai Medical Telescope, Voxmedia; Consultant: Amarin, Amgen, Boston Scientific, CryoLife S, CSLBehring, CVS Caremark, Daiichi Sankyo, Esperion, Gilead, Hengrui, Inari, Janssen, Novartis, Pfizer, PhaseBio Pharmaceuticals, St. Lukes, Samsung |
| Will Herrington, MA, MBBS, MD, FRCP | Personal fellowship and institutional grant funding: Medical Research UK and Kidney Research UK. Research support: Boehringer Ingelheim and Lilly. I follow a departmental policy to decline any honoraria from the pharmaceutical or food industry. |
| Dr. Patrick Holmes MB BS, MSc, DipTher, MRCGP | Consultant: AstraZeneca, NovoNordisk, Eli Lilly, Abbot; Speaker’s Bureau: AstraZeneca, Boehringer Ingelheim, NovoNordisk, Eli Lilly; Research Grant Recipient: NovoNordisk, Roche |
| Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP | Speaker: Dexcom, Abbott, Novo Nordisk ; Consultant: Insulet, Lilly, Cequr, Medtronic, Sanofi |
| Stefan James | Clinical Trial Steering Committee: AstraZeneca, Jansen, Bayer, Elixir; Consulting: Medtronic |
| Sanjit Jolly | Institutional Research Grant: Boston Scientific; Consultant Fee: Medtronic |
| Sergio Emanuel Kaiser, M.D., MSc, PhD, FACC, FESC | Speaker, Consultant, Investigator: Novo Nordisk; Speaker and Consultant: Astrazeneca; Speaker: Novartis, Bayer, Behringer Ingelheim, Merck Serono, Daiichi Sankyo |
| Darae Ko, MD, MSc | Advisory Board: Eagle Pharmaceuticals, Inc; Research Grant: Boston Scientific Corp; Speaker: CME Outftters, LLC |
| Mikhail Kosiborod, MD | Consultant/Advisor: Alnylam; Amgen Inc.; Applied Therapeutics; AstraZeneca Pharmaceuticals; Bayer AG; Boehringer Ingelheim International GmbH; Cytokinetics; Eli Lilly and Company; Janssen Global Services, LLC; Lexicon; Merck & Co., Inc. (Diabetes and Cardiovascular); Novo Nordisk A/S; Pharmacosmos; Sanofi; Vifor Pharma; Grant/Research Support: AstraZeneca Pharmaceuticals; Boehringer Ingelheim International GmbH |
| Edgar V. Lerma | Speaker’s Bureau: AstraZeneca; Bayer; Otsuka Consultant: Vifor; Otsuka; Bayer |
| Jane A. Linderbaum, MS APRN, CNP, FACC, FPCNA | Nothing to disclose |
| Niels D. Martin, MD, FACS, FCCM | Consultant/Advisor/Speaker: AstraZeneca; Consultant: Nestle, FloBio |
| Stephan A. Mayer, MD, FCCM, FNCS | Advisory Board: AstraZeneca |
| Taher Modarressi, MD | Speakers’ Bureau: AstraZeneca |
| Ahmad Masri | Research Grants: Pfizer, Akcea, Ionis, Ultromics; Honoraria: Pfizer, Alnylam, Eidos, Akcea, Ionis, Cytokinetics, BMS; Consultant: Attralus, Tenaya, Ionis |
| Roxana Mehran, MD | Consultant/Advisor: Abbott; Boston Scientific; Bristol Myers Squibb; CardiaWave; CHIESI USA, Inc.; Concept Medical; CineMed; Daiichi Sankyo, Inc.; Idorsia Pharmaceuticals; Janssen Global Services, LLC; Medtronic; Medscape; Novartis AG; Regeneron Pharmaceuticals; Spectranetics/Philips/Volcano Corporation; WebMD Grant/Research Support: Abbott; Abiomed; Applied Therapeutics; AstraZeneca Pharmaceuticals; Bayer AG; Bristol Myers Squibb; Cerecor Inc; CHIESI USA, Inc.; Concept Medical; CSL Behring; Daiichi Sankyo, Inc.; Medtronic; Novartis AG; OrbusNeich; Zoll Medical Corporation Speaker’s Bureau: Boston Scientific; CineMed; Janssen Global Services, LLC; Medscape; WebMD Equity: Applied Therapeutics; Elixir Medical; STEL |
| Erin D. Michos | Advisory Board: Novartis, Esperion, Amarin, AstraZeneca |
| Dr Ahmed Mohsen, MD, MSc. | Nothing to disclose |
| Nicholas Morris, M.D. | Nothing to disclose |
| Katelyn O’Brien, PharmD, BCPS, CDCES | Nothing to disclose |
| Iacopo Olivotto | Consultant: BMS, Cytokinetics, Amicus, Shire Takeda, Genzyme, Rocket Pharma, Tenaya |
| Charles V. Pollack Jr., MD (Course Chair) | Grant/Research Support: AstraZeneca Pharmaceuticals, eXIthera Pharmaceuticals, Provepharm US; Consultant/Advisor: AstraZeneca Pharmaceuticals, eXIthera Pharmaceuticals, Provepharm US, PhaseBio Pharmaceuticals, orexo, VERO Biotech, Milestone Pharmaceuticals |
| Richard Pratley, MD | Consultant/Advisor: Merck & Co., Inc.; Novo Nordisk A/S; Pfizer; Sanofi; SCOHIA PHARMA, Inc.; Sun Pharmaceutical Industries Ltd. Grant/Research Support: Hanmi Pharmaceutical Co.; Metavention; Novo Nordisk A/S; Poxel SA Speaker’s Bureau: Allergan; Novo Nordisk A/S |
| Dr. Amar Puttanna | Speaker’s Bureau: Novo Nordisk, Lilly-Boehringer Ingelheim, Sanofi, Daiichi- Sankyo, AstraZeneca; Consulting: Sanofi |
| Brian Rifkin, MD | Nothing to disclose |
| Katherine Sandquist | Nothing to disclose |
| Naveed Sattar | Consulting/speaker honoraria: Abbott Laboratories, Afimmune, Amgen, AstraZeneca, Boehringer Ingelheim, Eli Lilly, Hanmi Pharmaceuticals, Janssen, MSD, Novartis, Novo Nordisk, Pfizer, Roche Diagnostics, Sanofi; Grants: AstraZeneca, Boehringer Ingelheim, Novartis, Roche Diagnostics |
| Pam R. Taub, MD, FACC, FAPSC | Consultant: Amgen, Medtronic, Bayer, Boehringer Ingelheim, Esperion, Novartis, Novo Nordisk, Amarin |
| Dr. Ritu Thamman | Consultant: Bayer |
| Paul D. Thompson, MD | Consultant: Amgen, Regeneron, Esperion, and Sanofi; Research Support: Sanofi, Regeneron, Esperion, Amarin, Norvartis and Pfizer; Owns Stock: Abbvie, Abbott Labs, CVS, General Electric, Johnson & Johnson, Medtronic, and Sarepta; Provided Legal Consultation on exercise-related cardiac events and statin myopathy |
| Carlo Nemesio Trinidad, MD, FPCP, FPSN | Speaker: AstraZeneca; Corbridge Philippines; Otsuka; Sanofi |
| Dr Sourabh Sharma | Nothing to disclose |
| Deborah Siegal MD MSc FRCPC | Honoraria: BMS-Pfizer, Leo Pharma, Servier |
| Natalie Staplin, PhD | Research funding paid to institution for EMPA-KIDNEY trial: Boehringer Ingleheim; Eli Lilly and Company. Research funding paid to institution ASCEND-PLUS trial: Novo Nordisk. |
| Alex C. Spyropoulos, MD, FACP, FCCP, FRCPC | Research Funding/ Consultant: Janssen; Consultant: Bristol Myers Squibb, Boehringer Ingelheim, Atlas Group, Alexion, Bayer |
| Dr. Alfonso Valle, MD, PhD | Nothing to disclose |
| Dr. Harriette Van Spall | Research Funding: Canadian Institutes of Health Research, Heart and Stroke Foundation of Canada |
| Jason Weatherald, MD | Advisory board participant: Acceleron; Advisory board participant, speaker’s bureau, research grant recipient: Janssen/Actelion; Shareholder: Precision Lung Consultants & Diagnostics; Clinical Trial investigator: Merck |
| Susan Weiner, MS, RDN, CDCES, FADCES | Nothing to Disclose |
All relevant financial relationships with ineligible companies for this educational content have been mitigated.